Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Assets
Amortized cost of fixed maturity securities valuation allowances	$ 137	$ 160
Amortized Cost	315,474	307,421
Mortgage loans valuation allowances	981	800
Real estate and real estate joint ventures - FVO	13,481	13,342
Real Estate Held-for-sale	79	65
Other Invested Assets - Leveraged and Direct Financing Leases	1,846	1,851
Other invested assets, at estimated fair value (2)	17,470	18,504
Premiums, reinsurance and other receivables relating to variable interest entities	31,251	29,761
Liabilities
Short-term Debt	$ 381	$ 465
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, Liquidation Preference, Value	$ 3,905	$ 3,905
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	1,195,220,577	1,194,168,628
Common stock, shares outstanding	673,293,988	689,211,065
Treasury stock, shares	521,926,589	504,957,563
Residential mortgage loans - FVO
Assets
Real estate and real estate joint ventures - FVO	$ 377	$ 378
Variable interest entities
Assets
Real estate and real estate joint ventures - FVO	197	183
Other invested assets, at estimated fair value (2)	520	424
Premiums, reinsurance and other receivables relating to variable interest entities	0	47
Liabilities
Short-term Debt	$ 97	$ 133